2018
DOI: 10.1016/j.cgh.2017.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Place of Death and Hospice Utilization Among Patients Who Die From Cirrhosis in the United States

Abstract: C irrhosis is the 12th leading cause of death in the United States. 1 Complications of cirrhosis, such as ascites, variceal hemorrhage, hepatic encephalopathy, and renal impairment have a negative impact on patients' health-related quality of life, and account for most deaths in patients with cirrhosis. 2 Palliative and hospice care programs can decrease the burden of symptoms, reduce hospitalization, and improve end-of-life care. 3 There are limited data on the utilization of hospice in cirrhosis; a populatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 8 publications
2
12
0
Order By: Relevance
“…At the end of life, 61%‐78% of patients with DC and 58% of Medicare beneficiaries with HCC not enrolled in hospice die in the hospital. ( 86 , 87 , 88 , 89 , 90 , 91 ) During these long inpatient stays, greater than 50% of patients with AdvLD receive mechanical ventilation, 16% receive dialysis, and 43% receive a blood transfusion, while 28% of patients with HCC use ICU care at the end of life. ( 90 , 92 ) Quality indicators for end‐of‐life care in patients with AdvLD include 1) adequate control of symptoms (pain and dyspnea) and 2) presence of GOC discussions that clarify surrogate decision makers and assure that care received is consistent with the patient’s goals.…”
Section: Resultsmentioning
confidence: 99%
“…At the end of life, 61%‐78% of patients with DC and 58% of Medicare beneficiaries with HCC not enrolled in hospice die in the hospital. ( 86 , 87 , 88 , 89 , 90 , 91 ) During these long inpatient stays, greater than 50% of patients with AdvLD receive mechanical ventilation, 16% receive dialysis, and 43% receive a blood transfusion, while 28% of patients with HCC use ICU care at the end of life. ( 90 , 92 ) Quality indicators for end‐of‐life care in patients with AdvLD include 1) adequate control of symptoms (pain and dyspnea) and 2) presence of GOC discussions that clarify surrogate decision makers and assure that care received is consistent with the patient’s goals.…”
Section: Resultsmentioning
confidence: 99%
“…3 However, previous work has that hepatology clinicians rarely engage patients with decompensated cirrhosis in ACP. 4,5 In this issue of JAMA Internal Medicine, Patel and colleagues 6 report the results of a qualitative study of the experience of ACP that was conducted through interviews with 42 patients with decompensated cirrhosis and 46 clinicians across 3 liver transplant centers. Several key findings emerged from these interviews.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with advanced liver disease experience high healthcare utilization as they approach end of life. Between 61 and 78% of patients with advanced liver disease die in the hospital [8][9][10][11][12]. While rates of hospice utilization have been gradually increasing over time, only 10% of patients with advanced liver disease receive hospice care services at death [8,13].…”
Section: Defining Advance Care Planningmentioning
confidence: 99%
“…Between 61 and 78% of patients with advanced liver disease die in the hospital [8][9][10][11][12]. While rates of hospice utilization have been gradually increasing over time, only 10% of patients with advanced liver disease receive hospice care services at death [8,13]. In addition to dying in hospitalized settings, patients with advanced liver disease also receive intensive medical care as they approach end of life.…”
Section: Defining Advance Care Planningmentioning
confidence: 99%